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Abstract
Background: Segmentation of pre-operative low-grade gliomas (LGGs) from magnetic resonance imaging is a crucial
step for studying imaging biomarkers. However, segmentation of LGGs is particularly challenging because they rarely
enhance after gadolinium administration. Like other gliomas, they have irregular tumor shape, heterogeneous
composition, ill-defined tumor boundaries, and limited number of image types. To overcome these challenges we
propose a semi-automated segmentation method that relies only on T2-weighted (T2W) and optionally post-contrast
T1-weighted (T1W) images.
Methods: First, the user draws a region-of-interest (ROI) that completely encloses the tumor and some normal tissue.
Second, a normal brain atlas and post-contrast T1W images are registered to T2W images. Third, the posterior
probability of each pixel/voxel belonging to normal and abnormal tissues is calculated based on information derived
from the atlas and ROI. Finally, geodesic active contours use the probability map of the tumor to shrink the ROI until
optimal tumor boundaries are found. This method was validated against the true segmentation (TS) of 30 LGG patients
for both 2D (1 slice) and 3D. The TS was obtained from manual segmentations of three experts using the Simultaneous
Truth and Performance Level Estimation (STAPLE) software. Dice and Jaccard indices and other descriptive statistics
were computed for the proposed method, as well as the experts’ segmentation versus the TS. We also tested the
method with the BraTS datasets, which supply expert segmentations.
Results and discussion: For 2D segmentation vs. TS, the mean Dice index was 0.90 ± 0.06 (standard deviation),
sensitivity was 0.92, and specificity was 0.99. For 3D segmentation vs. TS, the mean Dice index was 0.89 ± 0.06,
sensitivity was 0.91, and specificity was 0.99. The automated results are comparable with the experts’ manual
segmentation results.
Conclusions: We present an accurate, robust, efficient, and reproducible segmentation method for pre-operative LGGs.
Introduction
Magnetic resonance (MR) imaging is a non-invasive
medical imaging technique that provides excellent soft
tissue contrast and has become the standard imaging
technique for brain tumor diagnosis [1]. Gliomas are
the most frequent primary brain tumors [2] originating
from glial cells and can be classified into four World
Health Organization (WHO) grades (I, II, III, and IV)
based on their aggressiveness [3]. Grade I tumors are
distinctive in the population (pediatric) and location (often
posterior fossa) and constitute a distinct group. The
Grade II or ‘Low Grade Gliomas’ (LGGs) are a more
challenging group that more frequently affects young
adults. LGGs are subdivided based on the microscopic
appearance of the tumor into oligodendrogliomas, as-
trocytomas, and mixed or other gliomas [4]. Compared to
high grade gliomas (HGGs), LGGs are less aggressive
tumors with better prognosis [4]. In addition, assessment
of tumor type and genetic biomarkers (e.g., 1p19q status)
may provide valuable information on the response of a
given therapy for LGG [4, 5]. Accurate and reproducible
segmentation of LGGs is a pre-requisite step for
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investigating imaging biomarkers that might be related to
tumor types and genetic biomarkers.
Manual segmentation of brain tumors is a tedious task
with low reproducibility. To avoid this, many semi- and
fully-automated segmentation methods have been pro-
posed for brain tumors. Most of these segmentation
methods involve classification or clustering approaches
[6–10] and have been targeted for HGGs [11]. In addition,
most of these approaches require multi-modal datasets for
accurate segmentation. Lacking just a single imaging
channel renders these segmentation methods unusable.
Pre-operative imaging for LGGs is less consistent and all
imaging types are not always available; we have found that
only pre- or post-contrast T1-weighted (T1W) and T2-
weighted (T2W) MR images are consistently available for
pre-operative LGGs. This eliminates the use of most clas-
sification and clustering approaches for pre-operative
LGGs. Edge or region based approaches [12–14] either
alone or in combination with classification approaches
[15–18], which are based only T2W or T1W images, are
more suitable for segmentation of pre-operative LGGs. In
some of these approaches [15, 16], normal brain atlases
were used to derive prior spatial knowledge. Kaus et al.
[15] presented a template-driven classification technique
that involves iterative statistical segmentation of LGGs
based on T1W MR image intensity values. This method
requires manual selection of four points for each tissue
type for initialization of the algorithm. An anatomical atlas
is used to derive the spatial location of anatomic struc-
tures by nonlinear registration of the atlas to each patient’s
data. The main limitation of this method is that it fails to
properly segment heterogeneous LGGs. Ho et al. [14] pro-
posed a level set evolution method to segment brain
tumors. They estimated a tumor probability map from im-
ages obtained from subtraction of post- and pre-contrast
T1W images and used it as a local guide for a level set
snake propagation. Moon et al. [19] and Prastawa et al.
[17] proposed a probabilistic tissue classification method
based on expectation and maximization (EM) for segmen-
tation of brain tumors. Images obtained from subtraction
of post- and pre-contrast T1 weighted images are used for
segmentation. However, it is known that not all LGGs en-
hance on post-contrast MRI [4]. Therefore, these methods
may fail for non-enhancing tumor cases. Prastawa et al.
[16] extended their previous work by an atlas based seg-
mentation method using T2W images and tested it on a
limited data (three tumors). However, tumors show wide
variety of intensity characteristics on T2W images. Fur-
thermore, tumor growth can deform brain tissue in great
degree and makes use of normal brain atlas difficult for
segmentation. Hamamci et al. [12] presented a cellular au-
tomata technique combined with graph theoretic methods
to segment brain tumors in post-contrast MR images.
This method might suffer from heterogeneous tumors
that include multi-component boundaries. Harati et al.
[13] presented a fully automated tumor segmentation
based on fuzzy connectedness on post-contrast T1W
images. This method detects tumor seed points automat-
ically based on tumor appearance in post-contrast T1W.
Sachdeva et al. [18] proposed a content-based active con-
tour for segmentation of brain tumors in different types of
MR images (i.e., pre-contrast T1W, post-contrast T1W,
and T2W). The method uses both intensity and texture
information within the active contour to overcome seg-
mentation difficulties in intensity based techniques. This
method requires an initial contour within the tumor re-
gion marked by the user and expands the contour through
the edge of the tumor with the content-based active con-
tour. However, having the initial contour or seed point
within the tumor and growing that might cause detection
of false boundary in heterogeneous tumors.
In our study, we present a combination of classifica-
tion and region based methods using atlas prior infor-
mation for segmentation of pre-operative LGGs from
T2W alone or T2W plus post-contrast T1W MR images.
We chose these two image types because they are nearly
universally acquired, even in image-guided biopsy exam-
inations. The purpose of this study was to propose an
accurate, reproducible, and semi-automated segmenta-
tion method that adapts different input images and satis-
fies the pre-requisite step for investigation of imaging
biomarkers of LGGs.
Method
We use a combination of two commonly acquired image
types, T2W and post-contrast T1W images, as input to
our segmentation algorithm. Figure 1 shows an example
of LGG image characteristics in post-contrast T1W and
T2W images.
Our segmentation algorithm consists of four main steps:
ROI creation, image registration, normal brain tissue
detection, abnormal brain tissue detection, and tumor
boundary detection. A flowchart of the algorithm is shown
in Fig. 2.
ROI creation
The first step of our method is the creation of a region-
of-interest (ROI) on the T2W image that completely en-
closes the tumor and some normal tissue (i.e., white and
gray matter). For 2D segmentation, the user draws an
ROI on an axial slice of the T2W image. The user must
avoid inclusion of cerebrospinal fluid (CSF) in the ROI
because CSF and tumors exhibit similar signal on T2W
MR images. For 3D segmentation, the user searches for
the largest diameter of the tumor on axial views and
clicks on the center of the tumor mass. Then, sagittal
and coronal views of the tumor for the selected coordin-
ate are displayed and the user draws an ROI that
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encloses the tumor on the sagittal and coronal views as
shown in Fig. 1.
Image registration
Our segmentation algorithm consists of two image regis-
tration tasks. We used the ANTs open source software
library for image registration [20, 21]. The first registra-
tion task is intra-patient image registration, where post-
contrast T1W are registered to T2W images of the same
patient. For this purpose, we performed affine registra-
tion, which contains linear transformations (e.g. transla-
tion, rotation, and scaling), was satisfactory enough to
align our intra-patient images.
The second task is registration of a normal brain ana-
tomical atlas to the patient’s T2 image in order to obtain
prior normal tissue information. For this purpose, we
used the SRI24 atlas [22] that was created using MR
images acquired at 3T in a group of 24 normal control
subjects. It provides anatomical images (T1W, T2W, and
proton density) and probabilistic tissue images (CSF
probability, white matter (WM) probability, gray matter
(GM) probability, and tissue labels). We used the ana-
tomical T2W atlas image to register the patient’s T2W
image in a deformable manner using ANTs diffeomorphic
nonrigid registration model. In both of the registration
tasks, mutual information [23] was used as the similarity
metric.
Normal brain tissue detection
In this step, we obtain a prior normal brain tissue intensity
distribution. First, we apply the deformation field, which
was obtained through registration of the anatomical T2W
atlas and the subject’s T2W image, to the probabilistic atlas
images to find corresponding normal brain tissue in the
patient’s images (see Fig. 3). Next, we mask the previously
defined tumor ROI (TROI) in the registered probabilistic
atlas images to avoid contamination of normal brain tissue
with abnormal brain tissue. Afterward, we obtain samples
Fig. 1 An example of a LGG appearance in post-contrast T1W and T2W images with manually selected tumor ROIs in axial, sagittal, and coronal
views of T2W image
Fig. 2 Flowchart of the steps of the algorithm. Inputs (green), operations (red), and outputs (light blue). IT2: T2W image, IT1C: post-contrast T1W
image, IA: atlas image, ĪT1C: registered post-contrast T1W image, ĪA: registered atlas image, TROI: Tumor ROI
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with high atlas probability >0.9 for each of the tissue classes
Γ ∈ {CSF, WM, GM} and model the intensity distribution
of each class using 2D Gaussian in the joint histogram (Ij
(s) = [ĪT1C (s), IT2 (s)] where s represents the spatial x,
y coordinates) of registered post-contrast T1W and




1 is the intensity mean in ĪT1C, μΓ
2 is the intensity
mean in IT2, and ΣΓ is the covariance of intensities of
ĪT1C and IT2. Finally, we refine the intensity distributions
of WM and GM by performing the EM algorithm to ob-
tain final distributions (see Fig. 3). In some cases, WM
and GM samples will be contaminated with CSF because
the registration step might be imperfect. To remove CSF
samples from WM and GM, we perform the EM with
initialization of two components (θCSF and θWM or θCSF
and θGM). The EM algorithm maximizes the likelihood
iteratively until it converges to a steady state and com-
putes the probability of each pixel belonging to each of
the components. In our algorithm, we consider the final
WM intensity distribution with parameter θN = θWM
* as
normal brain tissue prior distribution because it generally
represents the normal brain tissue around the tumor.
Abnormal brain tissue detection
In this step, we detect abnormal brain tissue within the
ROI, which encloses the tumor and some normal brain
tissue, by computing the posterior probability of each
pixel in 2D (or voxel in 3D) belonging to normal brain
tissue (N) and abnormal brain tissue (A). First, we con-
struct a joint histogram of the intensities of registered
post-contrast T1W (ĪT1C) and T2W images (IT2) within
the ROI and define a joint-intensity classifier. We model
the joint histogram by a mixture of 2D Gaussians, corre-
sponding to two classes: ψ ∈ {N, A}. Each class ψ is
modeled by a 2D Gaussian in the joint histogram, with
parameters θψ = {μψ
1 , μψ
2 , Σψ} where μψ
1 is the intensity
mean in ĪT1C, μψ
2 is the intensity mean in IT2 and Σψ is
the covariance of intensities of ĪT1C and IT2. The
initialization of parameter θN is obtained in the previous
step and the initialization of parameter θA is obtained
Fig. 3 An example of WM and GM after the tumor ROI is masked. WM (a) and GM (b) before tuning with EM. WM (c) and GM (d) after tuning with EM
Akkus et al. Cancer Imaging  (2015) 15:12 Page 4 of 10
from the initial TROI distribution. These initial parame-
ters are fed into a k-means clustering algorithm (k = 2)
and it runs until converging to a steady state. Afterward,
we compute the posterior probability P(ψi|Ij(s)) of each
observed pair of intensities (Ij (s) = [ĪT1C (s), IT2 (s)])
within the TROI based on Bayes’ Rule (Eq. 1).
Pðψi I j sð Þ
  ¼ pðI j sð Þ ψij Þ Pr ψið Þ
p Ij sð Þ
  ð1Þ
where p(Ij(s)|ψi) is the likelihood function, Pr(ψi) is the
class prior probability, and p(Ij(s)) is the marginal
likelihood.
The posterior probability of abnormal brain tissue
P(ψA|Ij(s)) > λ, where λ ∈ [0,1], is labeled as final abnor-
mal brain tissue P^ ψAð Þ
 
and assigned to maximum
probability (i.e., p = 1). The posterior probability map of
the patient in Fig. 1 is seen in Fig. 4a.
Tumor boundary detection
The final step of our algorithm is detection of the tumor
boundary by shrinking the initial user defined ROI
(TROI) to the tumor boundary. For this purpose, we used
geodesic active contours (GAC) adapted from [24]. The
posterior probability of abnormal tissue P^ ψAð Þ is used as
the input for the GAC. In the GAC, an energy functional
(E(C)) that depends on the image content is assigned to
a contour (C) and this energy is minimized until it
reaches a steady state (see Eq. 2).
E Cð Þ ¼
Z length Cð Þ
0
g ITð Þ C sð Þð Þds ;where IT ¼ P^ ψAð Þ;
g ITð Þ ¼ 1ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
1þ α ∇Gσ  ITj j
p
ð2Þ
where ∇Gσ ∗ is the first order Gaussian derivative filter
with standard deviation σ. g ITð Þ is low in the edges of
the image and high in the other parts of the image. α is
a constant to adjust gradient strength and empirically
set to 10. The minimization of the energy functional is
done in the steepest way with the level-set implementa-
tion [24]. The initial tumor ROI is considered as the
zero level-set and it propagates toward the tumor
boundary (see Fig. 4).
Tumor segmentation in 3D
The segmentation steps for 3D are the same as those de-
fined for the 2D segmentation, with adaptations for a 3D
volume, as described here. First, the volume is resampled
in the z direction with 1 mm slice thickness using B-
spline interpolation to reduce partial volume effects and
produce smoother segmentation results. Second, 3D seg-
mentation requires three ROIs as defined in section
2.1—namely, that coronal and sagittal ROIs are also cre-
ated on the ‘centroid’ slice. From these ROIs, the
minimum-bounding box in 3D that encloses the tumor
is created. Third, the surface of the bounding box
shrinks to the tumor boundary instead of the 2D curve
as defined in the previous section. The bounding box
may contain detached or attached objects (e.g., a part of
the CSF or skull) to the tumor. If separate objects are
detected in 3D segmentation results, they are discarded
by binary labeling, as the tumor label is known from the
ROI drawn on the axial slice. However, if there are ob-
jects attached to the tumor (e.g., a tumor close to the
ventricles), this requires post-processing to delete or dis-
connect these objects from the tumor by using a brush
tool and updated segmentation results.
Fig. 4 An example of tumor probability map (a) shown as an RGB image (Red: Normal tissue, Green: Abnormal tissue, Black: background) for the
initial ROI and final segmentation result obtained with GAC (b)
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Software implementation and computation
Our LGG segmentation algorithm was implemented in
Python programming language. The graphical user inter-
face (GUI) was built in QT (The QT Company Ltd.,
Digia PLC, Helsinki Finland) designer environment. The
image viewer part of the GUI was designed by using the
Python matplotlib library and embedded in the QT en-
vironment. The software includes several tools such as
bias field correction, skull stripping, image registration,
image segmentation, and interactive drawing tools.
To perform the experiments, we used a MacBook Air
(Apple Computer, Cupertino, CA) with a 1.4 GHz Intel
Core i5 processor and 8 GB 1600 MHz DDR3 RAM.
The algorithm takes ~1 min to perform intra-patient
image registration and, on average, 3 min for atlas regis-
tration. Drawing a 2D tumor ROI takes less than 10 s
and 3D typically is less than 30 s. The segmentation
process itself takes less than 5 s.
Dataset
Thirty pre-operative LGG patients were randomly se-
lected from our brain tumor patient database at Mayo
Clinic Institutional Review Board for this study. Institu-
tional Review Board (IRB) approval was obtained for this
study and patient consent was waived. Post-contrast
T1W and T2W weighted images were available for all
selected patients. All images had dimensions (x,y,z) of
256×256×Z where the number of images (Z) varied from
20 to 64 among patients. The mean voxel size was
0.84 × 0.84 × 4.3 mm3 with the Z thickness ranging from
3 to 5 mm.
Evaluation
In all thirty LGG patients, the axial slice with the lar-
gest tumor diameter was visually chosen and manually
segmented by three experts (A, L, J) for evaluation of au-
tomated segmentation. For this paper, we use the term
‘expert’ to refer to the manual tracings of tumor margins
or each person, and below, use the term ‘operator’ to refer
to the segmentations resulting from the semi-automated
software for each person. The intra-expert and inter-
expert variability were measured by computing coefficient
of variance (CV). The CV was calculated as follows:
CV(%) = 100 ⋅ (SDv/Meanv), where SDv and Meanv are
standard deviation and mean in slice volumes of three
manual segmentations. The three manual segmentations
were fed into STAPLE (Simultaneous Truth and Perform-
ance Level Estimation) software [25] to estimate the true
segmentation (TS). The STAPLE algorithm considers a set
of segmentations and computes a probabilistic estimate of
the TS. The performance of each manual and automated
segmentation was measured with the STAPLE algorithm.
Automated segmentation was performed in 2D and 3D
and was validated against TS for the same slice. For
evaluation of results, several metrics were generated such
as Dice Index (DI), Jaccard Index (JI), sensitivity p^ð Þ, spe-
cificity q^ð Þ , positive predictive value (PPV), and negative
predictive value (NPV) (see Eq. 3).
DI ¼ 2 A∩Bj j
Aj j þ Bj j ; J I ¼
A∩Bj j
A∪Bj j
where A and B are two tumor slice volumes.
p^ ¼ TP
TP þ FN ; q^ ¼
TN
TN þ FP ;
PPV ¼ TP




where TP = true positives, TN = true negatives, FN = false
negatives, FP = false positives.
We evaluated the intra-operator variability of auto-
mated segmentation results by comparing the results of
two ROIs drawn by the same operator two weeks apart.
For inter-operator variability of automated segmenta-
tion, we compared the segmentation results of two dif-
ferent operators using the CV metric.
Our method was also evaluated on a subset of LGG
data (25 patients) from BraTS (Brain Tumors Seg-
mentation Challenge, MICCAI 2014). A slice was se-
lected for each patient and automated segmentation
was validated against manual ground truth of one ex-
pert. We also compared our segmentation results to
the segmentation results from an EM algorithm in-
stead of posterior probability.
For selection of parameter λ, the threshold for being
classified as abnormal tissue, we divided our dataset into
two sets of 15 patients as training and test datasets, and
was evaluated for a range of values λ ∈ {0.1, 0.2, 0.3,
0.4, 0.5} to select the optimal λ value.
Results
The intra- and inter-operator variability for automated
segmentation is on the same order as intra-expert vari-
ability for manual segmentation and is about three times
lower than inter-expert variability for manual segmenta-
tion as seen in Table 1.
Table 2 shows the performance evaluation of each seg-
mentation compared to the STAPLE-derived TS. Expert A
had the highest sensitivity and the highest DI among the
Table 1 Intra- and inter-observer variability for manual and
automated segmentations
Manual segmentation Automated segmentation
Intra-expert Inter-expert Intra-operator Inter-operator
CV(%) 3.2 ± 3.1 9.5 ± 4.9 2.3 ± 2.4 3.7 ± 2.5
Units are in percentage (%)
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experts. Comparing experts L and J, we observe that they
have similar DI. However, expert J has higher sensitivity
than expert L. This means that expert L comparatively
underestimates segmentations and expert J comparatively
overestimates segmentations. First segmentations by
the first operator (Op1), second segmentations by the
first operator (Op1’), segmentations by the second oper-
ator (Op2), and segmentations using only T2W images
(T2W) have approximately similar sensitivity and DI. 3D
segmentation has slightly lower sensitivity compared
to 2D segmentation. Automated segmentations have
higher sensitivity than expert L but lower sensitivity than
experts A and J. DI of automated segmentations are
nearly the same order with the DI of experts L and J. Seg-
mentations using EM had lower sensitivity and DI com-
pared to our proposed method. In particular, EM
underestimates segmentation in heterogeneous tumors
as seen in Fig. 5. Segmentation results of our method for
four LGG cases are shown in Fig. 6.
Table 3 shows the evaluation of the probability threshold
(λ) for being abnormal brain tissue. As seen in Table 3, the
segmentation results for λ > 0.1 have almost identical DI
with only a slight difference. We chose the value λ = 0.3,
which gave the best DI in the training set.
When evaluating our algorithm with BraTS 2014 Chal-
lenge subset data, we obtained DI = 0.85 ± 0.17. This is
comparable to the results shown on the BraTS competi-
tion website (DI are in the range of 0.74-0.85) [26].
Table 2 Performance of all segmentations compared to STAPLE
true segmentation
p^ q^ PPV NPV DI JI
A 0.979 0.999 0.965 0.999 0.97 ± 0.05 0.94 ± 0.08
L 0.883 0.998 0.951 0.996 0.91 ± 0.06 0.84 ± 0.09
J 0.967 0.996 0.882 0.999 0.92 ± 0.08 0.86 ± 0.11
Op1 0.922 0.996 0.893 0.997 0.90 ± 0.06 0.82 ± 0.09
Seg3D 0.907 0.996 0.879 0.997 0.89 ± 0.06 0.80 ± 0.09
Op2 0.916 0.997 0.900 0.997 0.90 ± 0.05 0.82 ± 0.08
Op1’ 0.914 0.996 0.896 0.997 0.90 ± 0.06 0.82 ± 0.09
T2W 0.920 0.996 0.893 0.997 0.90 ± 0.06 0.82 ± 0.09
EM 0.830 0.996 0.906 0.994 0.84 ± 0.17 0.75 ± 0.18
A, L, J: Experts’ manual segmentations. Op1: First operator’s segmentation.
Seg3D: Segmentation in 3D. Op2: Second operator’s segmentation. Op1’:
Second segmentation of the first operator. T2W: Segmentation using only T2W
images. EM: Segmentation using EM
Fig. 5 An example of our segmentation result for a heterogeneous tumor. a initial ROI. b final segmentation with our posterior probability estimation.
c probability map obtained with EM. d probability map obtained with our posterior probability estimation for the initial ROI. Probability maps are
shown as an RGB image for the initial ROI. Red: Normal brain tissue. Green: Abnormal brain tissue. Black: Background
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To make a comparison between 3D segmentation re-
sults with and without post-processing (PP), average DI
and standard deviation is 0.89 ± 0.6 (with PP) vs. 0.87 ± 0.6
(without PP) for one slice validation against STAPLE TS.
Discussion
We present an accurate and reproducible segmentation
method for pre-operative LGGs using T2W or combined
T2W and post-contrast T1W images. Our method is
semi-automated; robust to heterogeneous composition,
irregular tumor shape, and ill-defined tumor boundaries;
and adaptive to inputs of different image types. As
Fig. 6 Examples for segmentation result of our method. First column: Initial ROI on T2W images (left-most). Second column: Posterior probability
map for ROI. Probability maps are shown as an RGB image for the initial ROI. Red: Normal brain tissue. Green: Abnormal brain tissue. Black: Background.
Third and Forth columns: Final tumor boundaries on T2W and post-contrast T1W images
Table 3 Dice index for training and test set for evaluation of λ
parameter
Dice index λ
0.1 0.2 0.3 0.4 0.5
Training set 0.78 ± 0.22 0.88 ± 0.06 0.89 ± 0.06 0.88 ± 0.07 0.88 ± 0.07
Test set 0.78 ± 0.22 0.89 ± 0.06 0.92 ± 0.05 0.92 ± 0.04 0.92 ± 0.03
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mentioned before, there have been several studies for
automated brain segmentations. However, most of the
methods [6–8] require multi-channel datasets and lack-
ing just a single imaging channel renders them useless.
These methods cannot be applied to segmenting pre-
operative LGGs that have only T2W and post-contrast
T1W MR images. Segmentation of single or limited im-
aging channels would likely require user inputs to
increase accuracy of segmentation. As a result, semi-
automated methods are used to improve accuracy and
narrow the search field. In some studies [14, 17, 19],
images acquired by subtraction of post- and pre-
contrast T1W images were used for segmentation.
However, the vast majority of LGGs do not enhance
after administration of intravenous contrast. This will
limit the use of contrast enhancement based methods
for LGG segmentation. Other studies [16, 18] use a
user defined ROI within the tumor as an initialization
and grow it to the tumor boundary. However, this may
cause failure in heterogeneous tumors, which often
contain areas of low signal that confound such
methods. To avoid this, we draw an ROI that encloses
the tumor and some normal tissue and shrink the ROI
through the normal brain tissue to the boundary of ab-
normal brain tissue.
As seen in Table 1, intra-operator variability is lower
than intra-expert variability and inter-operator variability
is much smaller than inter-expert variability. In particular,
inter-operator variability is almost on the same order with
intra-expert variability, which means that our method pro-
vides more reproducible segmentation results than man-
ual segmentation by experts with low variability.
As seen in Table 2, performance of our automated
methods is better than the performance of one expert and
close to the performance of the other two experts. Using
only T2W images for segmentation shows slight differ-
ences in results compared to using combined T2W and
post-contrast T1W images. This shows that there is no
significant benefit of using combined T2W and post-
contrast T1W images for segmentation in our dataset.
However, using combined T2W and post-contrast T1W
images might improve segmentation in heterogeneous
tumor cases as it provides extra information. The per-
formance of 3D segmentations shows that we can obtain
results approaching the better 2D segmentation results.
However, 3D segmentation requires additional user inter-
actions for final segmentation results. EM had the worst
performance. EM’s relatively poor performance may be
attributable to the fact that it underestimates segmenta-
tion in heterogeneous tumors (see Fig. 5).
Our semi-automated method results are comparable
to fully automated segmentation results in BraTS chal-
lenge [26]. Segmentations of pre-operative LGGs lie in
the range of fully automated methods - yet offering the
potential of segmenting limited datasets that consist of
T2W or T2W and post-contrast T1W MR images only.
As indicated previously, the specific aim of our methods
is to provide accurate and reproducible segmentations of
pre-operative LGGs, relying on T2W and optionally post-
contrast T1W images an important pre-requisite step for
investigation of imaging biomarkers of LGGs. A limitation
of our study is not being able to distinguish between
edema and tumor. We consider both as abnormal tissue.
Including T2W FLAIR images may allow segmenting
edema in another iteration after boundary detection of ab-
normal brain tissue. Segmentation results in pre-operative
LGGs may be useful as initialization for segmentation of
post-operative LGGs, which is more difficult due to resec-
tion and CSF infiltration. For post-operative LGGs assess-
ment, inclusion of T2W FLAIR will be necessary to
distinguish between CSF and abnormal tissue signal. Fur-
thermore, our method can be extended for further assess-
ment of LGG imaging biomarkers such as longitudinal
tumor growth rate, cerebral blood volume, and apparent
diffusion coefficients by including other imaging modal-
ities which may allow better prognosis for LGGs.
While we did not measure the operator time for our
method, it was clearly faster to provide approximate
boundaries in the case of 2D, and also faster to provide
just 3 ROIs versus tracing every slice for 3D.
Conclusion
In conclusion, our method provides accurate and repro-
ducible segmentations of pre-operative LGGs, relying on
T2W images, with optional T1W MR images. This is an
essential step for investigating imaging biomarkers of
LGGs and for tumor assessment on follow-up exams.
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